Roche's VENTANA FOLR1 (FOLR1-2.1) RxDx Assay Gets CE Mark In Ovarian Cancer Treatment
Swiss drug major Roche Group (RHHBY) announced Monday that it has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, ...
Roche receives CE Mark for Ventana FOLR1 RxDx Assay
Roche (RHHBY) announced that it has received CE Mark for its Ventana FOLR1 RxDx Assay. This is the first immunohistochemistry, or IHC, ...
360dx2h
Roche IHC Assay Nabs CE Mark as Companion Diagnostic for Abbvie's Elahere in Ovarian Cancer
The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.
AbbVie Receives European Commission Approval of ELAHERE® (mirvetuximab soravtansine) for the Treatment of Platinum-Resistant Ovarian Cancer
AbbVie (NYSE: ABBV) today announced the European Commission (EC) granted marketing authorization for ELAHERE® (mirvetuximab soravtansine) for the treatment of adult patients with folate receptor-alpha ...
Pharmabiz13h
AbbVie receives European marketing approval for Elahere for the treatment of platinum-resistant ovarian cancer
AbbVie receives European marketing approval for Elahere for the treatment of platinum-resistant ovarian cancer: North Chicago, Illinois Tuesday, November 19, 2024, 10:00 Hrs [IST] ...
Daily4h
AbbVie gets European Commission nod for Elahere for Platinum-Resistant ovarian cancer
AbbVie has announced the European Commission (EC) has granted marketing authorization for ELAHERE (mirvetuximab soravtansine) ...
precisionmedicineonline23h
AbbVie's Elahere Approved in Europe for FRα-Positive Ovarian Cancer
NEW YORK – The European Commission (EC) on Monday granted marketing authorization to AbbVie's Elahere (mirvetuximab soravtansine) as a new therapy option for previously treated patients with folate ...
pharmaphorum5d
ImmunoGen ELAHERE wins accelerated FDA approval for ovarian cancer
Additionally, VENTANA FOLR1 (FOLR1-2.1) RxDx Assay – Roche’s immunohistochemistry (IHC) companion diagnostic for identifying ovarian patients eligible for ELAHERE – has been ...
Variety6d
Ventana Sur Copia Final Title ‘All the Strength’ Ventures into the Superhero Realm (EXCLUSIVE)
Argentine writer-director-producer Luciana Piantanida is taking her completed sophomore pic, “All the Strength” (“Todas las fuerzas”) to Ventana Sur’s Copia Final where it will seek a ...
Variety6d
Latin America’s Top True Crime, Genre and Doc Series Projects Head to Ventana Sur’s Latam Series Market (EXCLUSIVE)
“Stolen Identity: Sexual Crime in the Digital Age” (Director: Sebastián Carreras; Argentina) ‘Stolen Identity: Sexual Crime in the Digital Age’ Courtesy of Ventana Sur A true crime ...
Yahoo News Canada6d
Ventana Sur Copia Final Title ‘All the Strength’ Ventures into the Superhero Realm (EXCLUSIVE)
Argentine writer-director-producer Luciana Piantanida is taking her completed sophomore pic, “All the Strength” (“Todas las fuerzas”) to Ventana Sur’s Copia Final where it will seek a sales agent, ...
Yahoo News Canada6d
Primer Corte, Copia Final at Ventana Sur: Bold First Features, Titles from Camila José Donoso, Redrum and Daniel Vega (EXCLUSIVE)
Camila José Donoso’s “Antitropical,” William Reyes’ “Eva,” and Manuel Ponce de Leon’s “In All My Journeys I Am Returning” are potential highlights at this year’s Ventana Sur industry centrepiece, its ...